C4 Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $131k | 36k | 3.60 |
| 2024-09-30 | $153k | 27k | 5.70 |
| 2024-06-30 | $119k | 26k | 4.62 |
| 2024-03-31 | $2.9k | 358 | 8.17 |
| 2023-12-31 | $7.4k | 1.3k | 5.65 |
| 2023-09-30 | $621 | 334 | 1.86 |
| 2023-06-30 | $855 | 311 | 2.75 |
| 2022-09-30 | $54k | 6.2k | 8.62 |
| 2022-06-30 | $4.0k | 502 | 7.97 |
| 2022-03-31 | $456k | 19k | 24.27 |
| 2021-12-31 | $1.0M | 31k | 32.19 |
| 2021-09-30 | $2.2M | 28k | 76.92 |
| 2021-06-30 | $0 | 35 | 0.00 |
| 2021-03-31 | $195k | 5.3k | 36.87 |
| 2020-12-31 | $1.3M | 39k | 33.16 |